HealthAstraZeneca Profit Rises 23%; Oncology Reaches 48% of RevenueBy Naomi CalderOct 30, 2026, 1:47 PM UTC
HealthPfizer Says Elrexfio Reduced Progression Risk in Myeloma TrialBy Naomi CalderOct 27, 2026, 10:31 PM UTC
HealthGSK Oncology Chief Tells WSJ Pipeline Could Nearly Double in 2027By Naomi CalderOct 27, 2026, 8:12 PM UTC
HealthLilly Highlights Four Oncology Data Sets for October ESMO CongressBy Naomi CalderOct 18, 2026, 10:17 PM UTC
